Skip to content

Advertisement

Call for papers – Precision Oncology

We are pleased to announce a new cross-journal thematic series on ‘Precision Oncology’ across a number of BMC journals within the oncology portfolio to help bring together the latest research on precision oncology.

The thematic series is now open for submission of original research and review articles (click on image above for more).

Featured review: BORIS: a key regulator of cancer stemness

This article by Soltanian & Dehghani comprehensive review on contradictory views on the expression pattern and biological function of BORIS in normal, as well as cancer cells/tissues, and presents some evidence that support the expression of BORIS in cancer stem cells (CSCs) and advanced stage/poorer differentiation grade of cancers. 

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

Read more

Articles

Most accessed articles RSS

View all articles

Research Data Support

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

New Associate Editors recruitment

New Content Item
Cancer Cell International invites you to join our team of academic editors in assessing manuscripts. For consideration, please send your CV to aoife.buckley@biomedcentral.com.

Editors-in-Chief

Y Eugene Chin, Shanghai Institute of Biological Sciences, China
Domenico Coppola, Moffitt Cancer Center, USA

Associate Editor spotlight

Matteo FassanMarilin Rosa

Dr. Marilin Rosa specializes in Breast Pathology and Cytopathology and serves as the Section Head of Breast Pathology at Moffitt Cancer Center and Research Institute in Tampa, Florida, USA. Dr. Rosa is also program director of the Breast Pathology Fellowship program at Moffitt. Her expertise is in breast cancer diagnosis, research, and education. Dr. Rosa’s research interests are identifying diagnostic, prognostic, and predictive biomarkers for breast cancer as well as studying cancer impact in low-resource/ minority populations.

Editorial Board spotlight

Sritama NathNives Pećina-Šlaus

Nives Pećina-Šlaus is a Professor at the Department of Biology and Head of the Laboratory of Neuro-Oncology Croatian Institute for Brain Research. She received her PhD from the School of Medicine, University of Zagreb, and has trained at Cold Spring Harbor Laboratory, New York, and Georgetown University, Washington DC. Dr. Pećina-Šlaus’ main fields are cancer genetics, Wnt signaling, genetics of brain tumors. She has authored more than 100 publications, including 63 scientific papers, a book, abstracts, book chapters and has received numerous awards e.g., from the Croatian Medical Association, Academy of Medical Sciences, University of Zagreb School of Medicine, and the National Science Award.

Advertisement

2017 Journal Metrics

Advertisement